News About: Pharm. Industry
Major drug companies caught in trap of slow growth.
87 leading pharmaceutical firms made the total sales at 4,575,400 million won in 1998, which was merely 2.3% increase from the previous year of 4,474,100 million won and 7.2% point lower than 1997 of 9.6%, indicating ...
Multinational drug corporations made favorable growth.
It is very interested to see a contrast phenomena in business management performances between the local and the foreign multinational drug corporations after the IMF economic turmoil. The foreign multinational corpora...
Insurance reimbursement plan for imported drugs postponed to Sept.
The insurance reimbursement plan for imported drugs as originally scheduled to implement from July 1 may be set aside to coming September largely on account of premature time for preparation of its launching and a str...
Foreign joint venture companies took over shares of their local partners.
A traditional concept of foreign joint venture business partnership between a foreign pharmaceutical company and a local partner has been no longer perceived. After the IMF economic crisis the world top mu...
Insurance reimbursement price of imported drugs to review
The implementing schedule for the government insurance reimbursement and its pricing plan of imported drugs from upcoming July 1 has to be postponed largely in consideration with possible international trade frictions...
Minimum price system strongly to be requested by foreign Multinational drug makers.
In line with the government plan for medical insurance reimbursement approval on imported drugs the foreign multinational drug corporations put their total efforts firmly to keep compliance to so-called "Minimum Price...
Imported drug insurance plan requested one year postponement.
The Korea Pharmaceutical Trade Association (KPhTA) presented an official position paper to the MOHW titled "Proposal for insurance drug pricing of imported drugs" indicating that imported drugs under the current insur...
Insurance drug price slash to hold possibly for long time.
The government price reduction plan for insurance drugs as scheduled to take effect from coming July 1, this year goes very likely to hold back for quite a long period of time in line with the implementation of new in...
Drug industry alert to public prosecutor's inspection on irrational drug deals.
Recently the public prosecutor investigated hospitals on bribery and rebate scandals in connection with hospital purchases of expensive medical instruments, which seems to be extended to the drug purchasing deals as w...
Low import drug pricing may hamper entry of new drugs.
Due to unreasonable price policy on the imported drugs currently proceeded in the government a new drug especially in use of difficult diseases seems hardly to be introduced into Korean market. The government insuranc...
